IL6 and Hyperglycemia: This may be related to the continuous activation of cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in diabetic patients [47], and the fact that hyperglycemia is associated with ROS production, leading to oxidative stress [48].